[Clinical efficacy, nephrotoxicity and ototoxicity of amikacin]. 1979

P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler

The clinical efficacy and toleration of amikacin was investigated in 22 patients most of whom had chronic urinary tract infections that had already been treated unsuccessfully on several occasions with other antibiotics. Amikacin was administered i.m. in a dosage of 7.5 mg per kg twice daily for an average of 11.4 days. This new aminoglycoside antibiotic proved highly effective in the treatment of chronic pyelonephritis and cystitis, as well as in septicaemia caused by gentamicin-resistant Pseudomonas. The pharmacokinetic studies did not show any retention after a ten day treatment with amikacin. Thorough nephrologic and otologic investigations for side-effects did not show any permanent nephrotoxic or ototoxic damage or delayed damage. The results were compared with the clinical and experimental data in the literature and with the results of experimental studies which have not yet been published.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006309 Hearing The ability or act of sensing and transducing ACOUSTIC STIMULATION to the CENTRAL NERVOUS SYSTEM. It is also called audition. Audition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
June 1977, The American journal of medicine,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
January 1993, Developmental pharmacology and therapeutics,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
June 1976, Antimicrobial agents and chemotherapy,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
April 2015, The Annals of otology, rhinology, and laryngology,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
June 1986, The American journal of medicine,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
October 2022, Medicine,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
January 1976, Infection,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
January 2016, Nigerian medical journal : journal of the Nigeria Medical Association,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
May 1977, The New England journal of medicine,
P Federspil, and K Schindler, and C Weich, and E Tiesler, and W Schätzle, and M Ziegler
October 1989, DICP : the annals of pharmacotherapy,
Copied contents to your clipboard!